In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

CMC Regulatory Strategies

PharmaNet Consulting professionals can help you design and manage an efficient manufacturing program, while keeping a watchful eye on regulatory compliance.
Our expert professionals support your Chemistry, Manufacturing, and Controls development to:

 

Select the best active ingredient candidates
Identify qualified vendors for cGMP manufacturing and studies of cGMP stability
Develop stability programs, according to ICH guidelines, for both lead and backup compounds
Select and manage a cGMP bulk-drug manufacturing campaign and subsequent
scale-up
Execute stability studies to select the most-compatible excipients
Determine the optimum formulation for the intended route of administration
Manage the cGMP clinical-supply manufacturing campaign
Prepare CMC summaries for regulatory submissions
Consult on GMP training and feasibility audits
Write standard operating procedures
Meet with regulatory authorities on CMC issues

 

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

William M. Egan, PhD

Executive Director, PharmaNet Consulting

 

Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

Mario Tanguay, BPharm, PhD

Vice President, Scientific and Regulatory Affairs, Anapharm

 

Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390